Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1994 Dec 15;304(Pt 3):861–867. doi: 10.1042/bj3040861

Characterization of a thioredoxin-related surface protein.

M F Dean 1, H Martin 1, P A Sansom 1
PMCID: PMC1137413  PMID: 7818492

Abstract

A surface-associated sulphydryl (thiol) protein (SASP) constitutively present in most nucleated cells was purified from human THP-1 monocytes and rat C6 glioma cells. The human protein was similar in mass and isoelectric point and had the same N-terminal amino acid sequence to adult T-cell leukemia-derived factor (ADF), a growth factor secreted by human lymphoid cells which is able to induce increased expression of interleukin-2 receptors. A further internal amino acid sequence, determined following cleavage of human SASP with cyanogen bromide, was also identical to the corresponding sequence deduced for ADF. Samples of SASP were able to reductively depolymerize human immunoglobulin, a property shared with thioredoxin, a ubiquitous protein, almost identical to ADF, with an essential function in many thiol-dependent reducing reactions. Furthermore, SASP purified from rat C6 glioma cells had an identical N-terminal amino acid sequence to that deduced for rat liver thioredoxin, showing that they were both members of the same family of proteins. The use of membrane-impermeable thiol reagents indicated that SASP was predominantly a cell-surface protein, and was not normally secreted. This SASP protein appeared to be a surface-associated form of thioredoxin that was constitutively present in a wide range of cells and was related to ADF, a secreted form of the same protein.

Full text

PDF
861

Images in this article

863Figure 3
on p.863
864Figure 4
on p.864
865Figure 6
on p.865
865Figure 7
on p.865

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. An G., Wu R. Thioredoxin gene expression is transcriptionally up-regulated by retinol in monkey conducting airway epithelial cells. Biochem Biophys Res Commun. 1992 Feb 28;183(1):170–175. doi: 10.1016/0006-291x(92)91624-y. [DOI] [PubMed] [Google Scholar]
  2. Auron P. E., Webb A. C., Rosenwasser L. J., Mucci S. F., Rich A., Wolff S. M., Dinarello C. A. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7907–7911. doi: 10.1073/pnas.81.24.7907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Balcewicz-Sablinska M. K., Wollman E. E., Gorti R., Silberstein D. S. Human eosinophil cytotoxicity-enhancing factor. II. Multiple forms synthesized by U937 cells and their relationship to thioredoxin/adult T cell leukemia-derived factor. J Immunol. 1991 Oct 1;147(7):2170–2174. [PubMed] [Google Scholar]
  4. Bennett C. F., Balcarek J. M., Varrichio A., Crooke S. T. Molecular cloning and complete amino-acid sequence of form-I phosphoinositide-specific phospholipase C. Nature. 1988 Jul 21;334(6179):268–270. doi: 10.1038/334268a0. [DOI] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  6. Eklund H., Gleason F. K., Holmgren A. Structural and functional relations among thioredoxins of different species. Proteins. 1991;11(1):13–28. doi: 10.1002/prot.340110103. [DOI] [PubMed] [Google Scholar]
  7. Forman-Kay J. D., Clore G. M., Driscoll P. C., Wingfield P., Richards F. M., Gronenborn A. M. A proton nuclear magnetic resonance assignment and secondary structure determination of recombinant human thioredoxin. Biochemistry. 1989 Aug 22;28(17):7088–7097. doi: 10.1021/bi00443a045. [DOI] [PubMed] [Google Scholar]
  8. Grippo J. F., Holmgren A., Pratt W. B. Proof that the endogenous, heat-stable glucocorticoid receptor-activating factor is thioredoxin. J Biol Chem. 1985 Jan 10;260(1):93–97. [PubMed] [Google Scholar]
  9. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem. 1989 Aug 25;264(24):13963–13966. [PubMed] [Google Scholar]
  10. Holmgren A. Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J Biol Chem. 1979 Oct 10;254(19):9627–9632. [PubMed] [Google Scholar]
  11. Holmgren A. Thioredoxin. 6. The amino acid sequence of the protein from escherichia coli B. Eur J Biochem. 1968 Dec 5;6(4):475–484. doi: 10.1111/j.1432-1033.1968.tb00470.x. [DOI] [PubMed] [Google Scholar]
  12. Johnson R. S., Mathews W. R., Biemann K., Hopper S. Amino acid sequence of thioredoxin isolated from rabbit bone marrow determined by tandem mass spectrometry. J Biol Chem. 1988 Jul 15;263(20):9589–9597. [PubMed] [Google Scholar]
  13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  14. Lafage-Pochitaloff-Huvalé M., Shaw A., Dessarps F., Mannoni P., Fradelizi D., Wollman E. E. The gene for human thioredoxin maps on the short arm of chromosome 3 at bands 3p11-p12. FEBS Lett. 1989 Sep 11;255(1):89–91. doi: 10.1016/0014-5793(89)81066-x. [DOI] [PubMed] [Google Scholar]
  15. March C. J., Mosley B., Larsen A., Cerretti D. P., Braedt G., Price V., Gillis S., Henney C. S., Kronheim S. R., Grabstein K. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature. 1985 Jun 20;315(6021):641–647. doi: 10.1038/315641a0. [DOI] [PubMed] [Google Scholar]
  16. Martin H., Dean M. Identification of a thioredoxin-related protein associated with plasma membranes. Biochem Biophys Res Commun. 1991 Feb 28;175(1):123–128. doi: 10.1016/s0006-291x(05)81209-4. [DOI] [PubMed] [Google Scholar]
  17. Matsuda M., Masutani H., Nakamura H., Miyajima S., Yamauchi A., Yonehara S., Uchida A., Irimajiri K., Horiuchi A., Yodoi J. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J Immunol. 1991 Dec 1;147(11):3837–3841. [PubMed] [Google Scholar]
  18. Pigiet V. P., Schuster B. J. Thioredoxin-catalyzed refolding of disulfide-containing proteins. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7643–7647. doi: 10.1073/pnas.83.20.7643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rozell B., Holmgren A., Hansson H. A. Ultrastructural demonstration of thioredoxin and thioredoxin reductase in rat hepatocytes. Eur J Cell Biol. 1988 Aug;46(3):470–477. [PubMed] [Google Scholar]
  20. Rubartelli A., Bajetto A., Allavena G., Wollman E., Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem. 1992 Dec 5;267(34):24161–24164. [PubMed] [Google Scholar]
  21. Rubartelli A., Cozzolino F., Talio M., Sitia R. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 1990 May;9(5):1503–1510. doi: 10.1002/j.1460-2075.1990.tb08268.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rubartelli A., Sitia R. Interleukin 1 beta and thioredoxin are secreted through a novel pathway of secretion. Biochem Soc Trans. 1991 Apr;19(2):255–259. doi: 10.1042/bst0190255. [DOI] [PubMed] [Google Scholar]
  23. Silberstein D. S., Ali M. H., Baker S. L., David J. R. Human eosinophil cytotoxicity-enhancing factor. Purification, physical characteristics, and partial amino acid sequence of an active polypeptide. J Immunol. 1989 Aug 1;143(3):979–983. [PubMed] [Google Scholar]
  24. Silberstein D. S., Dessein A. J., Elsas P. P., Fontaine B., David J. R. Characterization of a factor from the U937 cell line that enhances the toxicity of human eosinophils to Schistosoma mansoni larvae. J Immunol. 1987 May 1;138(9):3042–3050. [PubMed] [Google Scholar]
  25. Silberstein D. S., McDonough S., Minkoff M. S., Balcewicz-Sablinska M. K. Human eosinophil cytotoxicity-enhancing factor. Eosinophil-stimulating and dithiol reductase activities of biosynthetic (recombinant) species with COOH-terminal deletions. J Biol Chem. 1993 Apr 25;268(12):9138–9142. [PubMed] [Google Scholar]
  26. Singer I. I., Scott S., Hall G. L., Limjuco G., Chin J., Schmidt J. A. Interleukin 1 beta is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes. J Exp Med. 1988 Feb 1;167(2):389–407. doi: 10.1084/jem.167.2.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stemme S., Hansson H. A., Holmgren A., Rozell B. Axoplasmic transport of thioredoxin and thioredoxin reductase in rat sciatic nerve. Brain Res. 1985 Dec 16;359(1-2):140–146. doi: 10.1016/0006-8993(85)91421-0. [DOI] [PubMed] [Google Scholar]
  28. Söderberg B. O., Sjöberg B. M., Sonnerstam U., Brändén C. I. Three-dimensional structure of thioredoxin induced by bacteriophage T4. Proc Natl Acad Sci U S A. 1978 Dec;75(12):5827–5830. doi: 10.1073/pnas.75.12.5827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tagaya Y., Okada M., Sugie K., Kasahara T., Kondo N., Hamuro J., Matsushima K., Dinarello C. A., Yodoi J. IL-2 receptor(p55)/Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factor. J Immunol. 1988 Apr 15;140(8):2614–2620. [PubMed] [Google Scholar]
  30. Tagaya Y., Taniguchi Y., Naramura M., Okada M., Suzuki N., Kanamori H., Nikaido T., Honjo T., Yodoi J. Transcription of IL-2 receptor gene is stimulated by ATL-derived factor produced by HTLV-I(+) T cell lines. Immunol Lett. 1987 Jul;15(3):221–228. doi: 10.1016/0165-2478(87)90028-9. [DOI] [PubMed] [Google Scholar]
  31. Tagaya Y., Wakasugi H., Masutani H., Nakamura H., Iwata S., Mitsui A., Fujii S., Wakasugi N., Tursz T., Yodoi J. Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: involvement of dithiol related reduction. Mol Immunol. 1990 Dec;27(12):1279–1289. doi: 10.1016/0161-5890(90)90032-u. [DOI] [PubMed] [Google Scholar]
  32. Tonissen K. F., Robins A. J., Wells J. R. Nucleotide sequence of a cDNA encoding rat thioredoxin. Nucleic Acids Res. 1989 May 25;17(10):3973–3973. doi: 10.1093/nar/17.10.3973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Verner K., Schatz G. Protein translocation across membranes. Science. 1988 Sep 9;241(4871):1307–1313. doi: 10.1126/science.2842866. [DOI] [PubMed] [Google Scholar]
  34. Wakasugi N., Tagaya Y., Wakasugi H., Mitsui A., Maeda M., Yodoi J., Tursz T. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8282–8286. doi: 10.1073/pnas.87.21.8282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wedel N., Clausmeyer S., Herrmann R. G., Gardet-Salvi L., Schürmann P. Nucleotide sequence of cDNAs encoding the entire precursor polypeptide for thioredoxin m from spinach chloroplasts. Plant Mol Biol. 1992 Feb;18(3):527–533. doi: 10.1007/BF00040668. [DOI] [PubMed] [Google Scholar]
  36. Wollman E. E., d'Auriol L., Rimsky L., Shaw A., Jacquot J. P., Wingfield P., Graber P., Dessarps F., Robin P., Galibert F. Cloning and expression of a cDNA for human thioredoxin. J Biol Chem. 1988 Oct 25;263(30):15506–15512. [PubMed] [Google Scholar]
  37. Zingde S. M., Shirsat N. V., Gothoskar B. P. Peptide mapping of proteins in gel bands after partial cleavage with acidic cyanogen bromide vapors. Anal Biochem. 1986 May 15;155(1):10–13. doi: 10.1016/0003-2697(86)90216-2. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES